If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Trading Update

19 Jun 2020 12:15

RNS Number : 5329Q
Chamberlin PLC
19 June 2020
 

19 June 2020

Chamberlin plc

("Chamberlin" or the "Company")

 

Trading Update

 

Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, is pleased to provide a trading update following the announcement on 27 March 2020. 

 

The Company announces that the Walsall foundry reopened for production on 4 May 2020 following a three week closure. The machine shop, which also closed in April, has also reopened for production. While production levels at the Walsall factory are broadly in line with activity seen immediately prior to the impact from Covid-19, output levels at the Machine Shop are running at approximately 30% of that achieved before the COVID-19 measures.

 

Russell Ductile, the Company's Scunthorpe foundry operation, has remained open throughout and continues to operate at full production levels in response to customer demand. 

 

Petrel, Chamberlin's specialist lighting business has also remained open. However, due to suspension of a number of government and defence contracts, Petrel is operating at around 60% of normal sales volumes.

 

The health and safety of Chamberlin's employees has been, and remains, paramount. All operations are performed in line with relevant government guidelines and industry best practice specific to COVID-19 precautions. To date there have been no reported instances of any Chamberlin employee contracting COVID-19.

 

Chamberlin has taken advantage of the UK Government's measures to support business, including the furloughing of staff during the closure of the Walsall sites. The majority of employees are working normally with approximately 18% of the Company's workforce still furloughed.

 

Despite current levels of activity in the Walsall foundry being relatively high, the outlook for a number of the key markets, particularly across the automotive sector, remain uncertain. As a result, Chamberlin has taken steps to reduce costs in line with the expected reduction in demand.

 

Recognising the ongoing uncertainty across global markets, the Board continues to believe that it is too early to make any reasonable estimate of the financial impact on the Group during the current year and beyond.

 

The Company anticipates that the preliminary results for the year to 31 March 2020 will be announced in August 2020.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

 

 

Enquiries

 

Chamberlin plc

Kevin Nolan, Chief Executive

Neil Davies, Finance Director

 

T: 01922 707100

 

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Russell Cook

Katy Birkin

 

T: 020 7397 8900

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGPUWUQUPUGGB
Date   Source Headline
26th Nov 20137:00 amRNSHalf Yearly Results
31st Oct 201312:37 pmRNSHolding(s) in Company
15th Oct 20137:00 amRNSTrading Update
23rd Sep 20137:00 amRNSDirector/PDMR Shareholding
9th Sep 201310:48 amRNSDirector/PDMR Shareholding
2nd Sep 20137:00 amRNSAppointment of Chief Executive
15th Aug 20135:04 pmRNSDirector/PDMR Shareholding
13th Aug 20133:49 pmRNSHolding(s) in Company
13th Aug 20138:33 amRNSDirector/PDMR Shareholding
18th Jul 20133:09 pmRNSResult of AGM
18th Jul 20137:00 amRNSTrading Update
2nd Jul 20137:00 amRNSBoard Appointment
21st May 20137:00 amRNSBoard Change
21st May 20137:00 amRNSFinal Results
26th Apr 20137:00 amRNSTrading Update
28th Feb 20137:00 amRNSTotal Voting Rights
12th Feb 201310:32 amRNSHolding(s) in Company
5th Feb 20137:00 amRNSDirector/PDMR Shareholding
4th Feb 201312:04 pmRNSHolding(s) in Company
28th Jan 20137:00 amRNSTrading Statement
16th Jan 20138:48 amRNSHolding(s) in Company
11th Dec 20125:04 pmRNSDirectorate Change
10th Dec 20123:10 pmRNSDirector/PDMR Shareholding
5th Dec 20122:33 pmRNSStatement re Board
27th Nov 20127:00 amRNSHalf Year Results
15th Oct 20127:00 amRNSTrading Update
13th Sep 20122:51 pmRNSHolding(s) in Company
13th Sep 201210:00 amRNSHolding(s) in Company
22nd Aug 20124:11 pmRNSHolding(s) in Company
17th Aug 20127:00 amRNSHolding(s) in Company
16th Aug 20127:00 amRNSHolding(s) in Company
27th Jul 201210:23 amRNSReplacement - Director/PDMR Shareholding
27th Jul 20127:00 amRNSDirector/PDMR Shareholding
12th Jul 20123:43 pmRNSResult of AGM
12th Jul 20127:00 amRNSAGM Statement
22nd May 20127:00 amRNSFinal Results
17th Apr 20127:00 amRNSTrading Update
30th Mar 201211:55 amRNSTotal Voting Rights
19th Mar 20125:23 pmRNSDirector/PDMR Shareholding
1st Mar 20127:00 amRNSNew Chairman takes up appointment
21st Feb 201211:48 amRNSHolding(s) in Company
13th Feb 20123:39 pmRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSHalf Year Results
11th Oct 20117:00 amRNSTrading Update
3rd Oct 20111:51 pmRNSHolding(s) in Company
14th Jul 20114:46 pmRNSHolding(s) in Company
14th Jul 20113:25 pmRNSResult of AGM
14th Jul 20117:00 amRNSAGM Statement
13th Jul 20114:34 pmRNSHolding(s) in Company
7th Jul 20117:00 amRNSPlacing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.